Get informed when a big investor buys or sells
+ FollowOvervalued by 127.3% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $5.01 Million |
|---|---|
| Enterprise Value | $5.49 Million |
| Earnings per Share | $0 |
| Beta | -0.1 |
| Outstanding Shares | 50,923,430 |
| P/E Ratio | -100 |
|---|---|
| PEG | 95.58 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.44 |
| Enterprise Value to EBIT | 18.85 |
| Enterprise Value to Net Income | -138 |
| Total Debt to Enterprise | 0.09 |
| Debt to Equity | 0.69 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Kelyniam Global, Inc. operates as a medical device manufacturer, providing specialized solutions for patients. The company creates custom prosthetics using computer-aided design (CAD) and manufacturing (CAM) processes, employing advanced...